Legend Biotech (LEGN) EBITDA Margin Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,609.00 |
| Sep 30, 2025 | -2,469.00 |
| Jun 30, 2025 | -1,494.00 |
| Mar 31, 2025 | 8,220.00 |
| Dec 31, 2024 | -14,252.00 |
| Sep 30, 2024 | -16,755.00 |
| Jun 30, 2024 | -22,385.00 |
| Mar 31, 2024 | -39,638.00 |
| Dec 31, 2023 | -29,535.00 |
| Sep 30, 2023 | -29,091.00 |
| Jun 30, 2023 | -35,725.00 |
| Mar 31, 2023 | 9,963.00 |
| Dec 31, 2022 | 16,499.00 |
| Sep 30, 2022 | 1,546.00 |
| Jun 30, 2022 | 12,126.00 |
| Mar 31, 2022 | 9.82 Mn |
| Dec 31, 2021 | 304.00 |
| Sep 30, 2021 | -13,165.00 |
| Jun 30, 2021 | -4,301.00 |
| Mar 31, 2021 | -9.85 Mn |
| Dec 31, 2020 | -15,428.00 |
| Sep 30, 2020 | 29,103.00 |
| Jun 30, 2020 | 12,861.00 |